According to Rua Bioscience latest financial reports the cash on hand of RUA is $2.83M, an decrease of -54.11% to 2022. At the end of 2022 company had $6.17M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $2.83M | -54.11% |
2022 | $6.17M | -43.60% |
2021 | $10.93M | - |